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Abstract
Objective: The aim of the present study was to develop a toolkit combining various risk fac-
tors to predict the risk of developing a postpartum hemorrhage (PPH) during a cesarean section.
Study Design: A retrospective cohort study of 24,230 women who had cesarean delivery be-
tween January 2003 and December 2013 at a tertiary care teaching hospital within the United
Kingdom serving a multi-ethnic population. Data was extracted from hospital databases and
risk factors for PPH were identified. Hothorn et al.s Recursive Partitioning algorithm was used
to infer a conditional decision tree. For each of the identified combinations of risk factors two
probabilities were calculated: the probability of a patient producing 1000ml blood loss and
2000ml blood loss.
Results: The Leicester PPH Predict Score was then tested on the randomly selected remaining
25% (n=6095) of the data for internal validity. Reliability testing showed intraclass correlation
of 0.98 and mean absolute error 239.8ml with the actual outcome.
Conclusion: The proposed toolkit, which is available online, enables clinicians to predict the
risk of postpartum hemorrhage. As a result, preventative measures for postpartum hemorrhage
could be undertaken. Further external validation of the current toolkit is required.
Index terms— Postpartum hemorrhage, score, cesarean section, risk assessment tool, machine
learning, recursive partitioning
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1 Introduction
Postpartum hemorrhage (PPH) was highlighted by Mothers and Babies: Reducing Risk through
Audit and Confidential Enquires (MBRRACE) across the UK, as the second leading direct cause
of maternal death. The rate of maternal mortality per 100,000 after PPH, has been 0.59, 0.46 and
0.55 in the 2009-11, 2010-12 and 2011-13 reports respectively [1].
Given the severe morbidity that PPH can cause, several strategies have focused on recognizing
risk factors to predict those women at risk of PPH and offer enhanced management. The Royal
College of Obstetricians and Gynaecologists (RCOG) recommend being aware of both antenatal
and postnatal risk factors for PPH and to modify care plans accordingly, with major risk factors
including placenta previa or accreta, which are known to cause extreme PPH, being automatically
managed as high risk [2]. Other factors such as age, ethnicity [3, 4], emergency cesarean, obesity
[5], induction of labour [6], big baby [7], sepsis [8], hypertension [9], abruption [10], fibroids [11] and
multiple pregnancy [3] have been identified as moderate risk factors, but their impact in combination
has not been considered. It is possible that the combination of some of the moderate risk factors
could lead to high risk of PPH. It is clinically significant therefore, to estimate the collective impact
of such risk factors together, to support the identification of appropriate precautionary measures in
a timely manner.
Cesarean sections (CS) are associated with increased blood loss and world-wide CS rates are on
the rise [12]. It is therefore important that prophylactic measures aimed at reducing the risk of PPH
are incorporated into standard clinical practice. Previous prediction tools have not been validated
with further data analysis [13].
2 Objective
The objective is to identify the specific combinations of risk factors that can lead to a higher blood
loss during a CS, and to quantify these risks. The ability to accurately predict the risk of blood
loss would enable preventative measures to be undertaken, thus reducing the frequency of PPH and
the morbidity and mortality that follows. Secondly the newly developed tool-kit will be validated
within our multi-ethnic population.
3 Study Design
This study was performed as a retrospective cohort study at a University hospital trust in the
UK with a multi-ethnic population. Data of all CS performed at this trust between January 2003
and December 2013 was gathered from the hospital electronic database. Database searches were
supplemented by case notes review. Data for all women undergoing a CS was coded to include the
estimated blood loss at CS and 18 identified risk factors for PPH, shown in Table 1. Electronic text
was searched independently for risk factors not otherwise identified.
Patients were randomly split into two groups; a training group consisting of 75% (N=18,172) of
the patients, and a validation group consisting of the remaining 25% (N=6,058).
The training group was analysed by Hothorn et al.s non-parametric recursive partitioning algo-
rithm [15]. The algorithm starts by splitting the data into two sub-groups, according to the risk
factor that leads to the greatest statistically significant difference in terms of blood loss. The same
process is then repeated for the sub-groups with respect to different risk factors, continuing recur-
sively until a termination criterion is achieved (described below). The result is a decision tree [16],
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Table 1: Factors that can contribute to PPH.
Factor References
Previous Cesarean (CS) [13]
Antepartum / Intrapartum Hemorrhage [14]
Emergency Cesarean [4]
Age ≥ 40 [3]
Maternal Sepsis [3]
Suspected scar dehiscence [2]
Second stage section [2]
Polyhydramnios [3]
Macrosomia [2]
Fibroids [11]
Preeclampsia/ Pregnancy induced hypertension (PET/PIH) [3]
Multiple Pregnancy [3]
Previous 3 CS [13]
Asian Ethnicity [4]
Grandmultip [14]
Placenta Previa [2, 14]
Suspected Abruption [14]
whereby the root of the tree corresponds to a split along the lines of the most significant risk factor
that spans the entire population of patients, and branches correspond to sub-groups.
The minimal threshold for this splitting procedure is specified as the minimal statistical signifi-
cance that should be achieved by a given split (the maximum p-value). We selected this parameter
by a process of adaptive resampling [17]. Where several p-values were attempted, the final p-value
was chosen that produced the lowest Root Mean Squared Error computed by 5-folds Cross Valida-
tion. This led to the choice of a minimal threshold of 0.01. In other words, the recursive partitioning
would terminate if no split could be found that produced different blood loss levels where p < 0.01.
For each branch in the decision tree (i.e. every distinct group and sub-group of patients contained
in the tree), the blood loss data for that specific group of patients was analysed, and the probabilities
of producing a blood loss ≥ 1000ml and ≥ 2000ml were calculated.
The remaining 25% unseen data was used to validate the accuracy of the probabilities computed
for the various combinations of risk factors. For each of the identified combinations of risk factors,
the probabilities of the likelihoods of ≥ 1000ml and ≥ 2000ml blood loss were calculated, and were
compared to the corresponding probabilities for the training data. This comparison was quantified
in terms of how correlated the two sets of probabilities are, and is also in terms of the mean absolute
error, which was computed as: |p1.a1|+...+|pn.an|
n
, where pi denotes the predicted value for patient i,
and ai represents the actual value for patient i.
4 Results
A total number of 24,230 CS were included in this study of which 8,736 (36.1%) were elective and
15,494 (63.9%) were emergency procedures. 2,997 women had blood loss more than 1000ml out of
24,230 (12.4%).
From the 18 risk factors in the data, the recursive partitioning algorithm highlighted nine as
contributing, either individually or in combination with each other, to blood loss levels. The resulting
3
Figure 1: Decision tree produced by recursive partitioning, with added blood loss probabilities.
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Table 2: Statistics comparing PPH for sub-groups of patients with and without factors identified
within the decision tree.
Patients with factor Patients without factor
N Mean SD Median P(>1k) P(>2k) N Mean SD Median P(>1k) P(>2k) p-value
Placenta
previa
421 1372.337 1465.192 900 0.485 0.207 17751 631.741 412.25 500 0.117 0.02 <0.001
Placenta
previa &
Prev. CS
96 1964.865 2046.347 1000 0.583 0.312 325 1197.314 1191.761 800 0.455 0.175 <0.001
Ante /In-
trapartum
Haem.
315 1086.508 877.234 800 0.419 0.124 17436 623.526 394.154 500 0.112 0.018 <0.001
Prev. CS 5632 581.017 345.399 500 0.082 0.013 11804 643.808 413.883 500 0.125 0.02 <0.001
Prev.
CS and
Emerg.
CS
1865 613.592 421.183 500 0.102 0.018 3767 564.889 299.654 500 0.072 0.011 <0.001
Prev. CS
& BMI
≥35
377 640.268 370.874 500 0.103 0.013 3390 556.506 289.514 500 0.069 0.01 <0.001
Prev. CS
& Grand-
multip
80 693.875 599.315 500 0.138 0.062 3310 553.186 277.132 500 0.067 0.009 <0.001
BMI≥35 712 727.949 415.875 600 0.185 0.029 11092 638.407 413.188 500 0.122 0.02 <0.001
Asian
Ethn.
2478 602.494 396.593 500 0.1 0.017 8614 648.738 417.291 500 0.128 0.021 <0.001
Asian
Ethn. &
Mult.
Pregnancy
57 802.632 718.283 600 0.228 0.035 2421 597.782 384.819 500 0.097 0.017 0.002
Asian
Ethn. &
PET/PIH
91 460.989 138.805 500 0.011 0 2330 603.124 390.343 500 0.1 0.017 0.01
Emerg.
CS
6587 657.568 436.217 500 0.132 0.023 2027 620.041 347.318 500 0.115 0.012 0.007
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decision tree model is shown in Figure 1. To interpret this, one starts from the top node, which
starts from the most significant decision, and works down through the subsequent factors until a
leaf-node is reached, where the probability of blood loss being ≥ 1000ml and ≥ 2000ml is given.
The tree-structure imparts a hierarchy on the risk factors that are of particular concern for blood
loss. Faced with a patient with a multitude of potential risk factors, the tree-structure makes it clear
that the questions of placenta previa and previous CS take precedence over all others. Additionally,
the question of multiple pregnancies only appears to be a significant factor for Asian patients and
is overridden by the question of a large BMI index in any case.
Placenta previa is the main risk factor, leading to a 45.5% chance of 1000ml and a 17.5% chance
of ≥ 2000ml estimated blood loss (EBL) respectively. However, this is hugely exacerbated when
combined with a previous CS, where the probabilities rise to 58.3% and 31.2% respectively. Inde-
pendently, APH is associated with a 41.9% and 12.4% chance of an EBL ≥ 1000ml and ≥ 2000ml
respectively.
There are many different paths through the decision tree; the following are a few examples. Let
us consider a patient with no placenta previa or APH but there has been a previous CS, if the
subsequent CS is an emergency the patient has a 1 in 10 chance of PPH ≥ 1000ml. If it is not an
emergency but their BMI is greater than 35 the patient again has a PPH risk of 10.3%. Then, if
you do not have a raised BMI, whether you are a grandmultip becomes important and you have a
risk of 13.8% of EBL ≥ 1000ml.
If no history of previa, APH or previous CS, BMI is again an important risk factor and the risk
of ≥ 1000ml is 18.5%. If BMI was less than 35, the patient was of Asian ethnicity and it was a
multiple pregnancy, the associated EBL would be ≥ 1000ml in 22.8%. PET/PIH and being of Asian
origin was associated with low EBL of 1.1% of blood loss ≥ 1000ml.
Validation of the predictions for blood loss of ≥ 1000ml and ≥ 2000ml against the cohort of
patients who were not used for model inference indicates that the predictions are accurate. A
comparison of the probabilities predicted from the training data and the corresponding probabilities
within the validation data is shown in Figures 2 and 3. The mean absolute error is 239.8ml, which
is reasonably accurate, and the interclass correlation between the predicted mean EBL and actual
mean EBL 0.98. The correlation between percentage predicted ≥ 1000ml and actual blood-loss
≥ 1000ml is 0.97, shown in Figure 2. For ≥ 2000ml the correlation is 0.96, shown in Figure 3.
It is noteworthy that, contrary to previous results [11], the inferred model does not highlight
fibroids as influencing blood loss. This should not be interpreted as meaning that fibroids are not
a factor. However, our data set only contained 37 patients with fibroids (and the 75% sample
used for training the model contained only 28). Furthermore, many of these patients also exhibited
other factors that did feature in the model (only nine patients with fibroids did not have other
characteristics that also feature in the model). Nevertheless, looking at the statistics for those
patients with fibroids, the mean blood loss is 809.459ml, the probabilities of ≥ 1000ml and ≥ 2000ml
are 32.4% and 5.4% respectively, so the data (albeit with few data points) still corroborates that
the presence fibroids is a potentially significant factor.
5 Discussion
Risk models have been successfully used in medicine and surgery to prepare clinicians with safety
tools. These models help patients to understand their individualized risk, which is much closer
to reality than the background population risk. Such risk prediction helps patients to make an
informed decision and consider alternatives to proposed treatment. In surgery, Parsonnet et al
created an additive model to predict chance of mortality within 30 days after cardiac surgery for
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Figure 2: Comparison of predicted probabilities for EBL of ≥ 1000ml.
adult acquired heart disease [18]. It was then tested prospectively and shown to have excellent
correlation between anticipated and observed mortality. Like our current model, Parsonnets model
was based on the data from one unit. When applied to other units there was a slight variance
in predicted mortality, but it inspired Nashef et al to create the EuroScore using multicenter data
which is now a highly regarded and well used risk model [19]. The current model to predict PPH
could similarly form the foundation for a multi-centre study.
Risk factors for PPH have been described in other studies. Multiple pregnancy [2] causes extra
uterine distention compared to a singleton, making it less effective at returning to its contracted
state and susceptible to bleeding. Previa is associated with a high incidence of PPH in some studies,
which would be in agreement with our results [2, 14]. APH [14] and raised BMI [5] have been
previously associated with complications including PPH. The novel result of this study was the
ability to quantify and individualize the risk for women undergoing CS.
The proposed tool has many advantages over the traditionally used qualitative risk assessment
approach. In addition to improving patient safety and care, these models provide a base for stan-
dardized comparison of incidence of this complication across different units. Comparison of PPH
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Figure 3: Comparison of predicted probabilities for EBL of ≥ 2000ml.
rates alone without accounting for the complexity of patient risk factors and demographics could be
biased.
A paper risk assessment tool has been used to help prevent obstetric venous thromboembolism
(VTE) which is widely used and forms part of the RCOG green top for prevention of VTE [20].
The Leicester PPH Predict tool could form a part of the pre-theatre checklist and these tools are
increasingly being implemented as mobile apps in other specialities. Nogueira et al have created
an app to use prehospital to triage patients using simple yes/no answers to help direct them to the
appropriate hospital for their care [21]. Our tool has been developed into a free online website1.
This allows the user to click yes or no to each patient characteristic question, producing as output a
probability of blood loss ≥ 1000ml and ≥ 2000ml. This online tool is available to be used by other
units globally for clinical and research purposes, please note information inputted will be stored
anonymously on the website but not used for any purpose. This could also provide an opportunity
for external validity of this tool.
Medical data has increased in quantity over the last few decades and machine learning techniques,
1http://bit.ly/2eEtSn0
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such as we have used in our statistical analysis, allow far more complex relationships to be revealed
compared to standard methods of data processing. The decision tree is especially useful because
it is sensitive to the more subtle interrelationships between factors. So, for example in our model,
the question of whether you have had a previous CS is particularly important if you also had
a placenta previa. Scheer et al created a computer based preoperative predictive model for an
orthopaedic complication using a similar split of trained and untrained data. It was shown to have
86% accuracy at predicting the complication [22]. Jurarut et al developed a simple score system
using traditional multivariate analysis for predicting PPH in Thailand at CS using retrospective data
on 2,405 patients with an overall prevalence of PPH of 10.1% [13]. Similarly, they found previa,
emergency CS, multiparity to increase risk of PPH.
Having a risk assessment tool allows consideration of what might be required to prevent or deal
with the PPH. Those at lower risk would have the routine 5 units IV syntocinon. If stratified as
medium risk then administration of prophylactic 40 units or carbetocin and other oxytocics/ balloons
could be available if required. Then those at higher risk could be delivered in a unit with access to
cell salvage, gynecological theatre equipment, crossed matched blood, embolization, senior support
in theatre and vascular surgeon availability [23, 24, 25]. Preparations such as this are likely to be
routine when known extreme risk factors such as placenta previa are present, but this risk assessment
tool also takes into account when multiple minor risk factors add up and can lead to previously less
predictable high blood losses that would not normally trigger the same level of preventative care.
A limitation of this study is that it was performed at single center. However, this provides
the additional advantage of having uniform clinical protocols, practice and documentation for all
patients. Another limitation could be the use of estimated blood losses as documented in the notes
by trained staff rather than measured blood loss. This is due to the retrospective nature of this
study design. Yearly mandatory staff training includes correctly estimating blood loss with pictorial
reference cards and has improved estimations of blood loss over recent years. It is noteworthy that,
contrary to previous results [10], the inferred model does not highlight fibroids as major risk factor
for blood loss. However, this finding should be interpreted with caution as the current data set had
limited number of fibroid cases.
6 Conclusion
The Leicester Predict PPH tool predicts the risk of significant PPH following CS using preoperative
characteristics of the patient. This risk assessment tool showed reliable results when tested for
internal validity. The use of this tool in clinical practice will help to plan and execute the strategies to
minimise the blood loss in high risk patients. Such an approach of quantified individualized risk will
improve CS surgery safety and will also enable patients to make informed choices. Further research
using a prospective multi-center trial design to externally validate this toolkit is recommended.
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